Company Filing History:
Years Active: 2007
Title: Jean-Marc Jeltsch: Innovator in Cancer Diagnostics and Treatment
Introduction
Jean-Marc Jeltsch is a notable inventor based in Molsheim, France. He has made significant contributions to the field of cancer research through his innovative work on polypeptides and their applications in diagnosing and treating cancer. His dedication to advancing medical science is evident in his patent and collaborations with esteemed institutions.
Latest Patents
Jean-Marc Jeltsch holds a patent for the invention titled "ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer." This invention focuses on a novel ICBP90 (Inverted CCAAT box binding protein 90) and its fragments, as well as polynucleotides that code for these polypeptides. The patent also includes specific antibodies directed against these polypeptides. Furthermore, it outlines methods and kits for diagnosing cell proliferation and compounds that can be utilized as medicine for preventing and treating pathologies involving cell proliferation, particularly cancer.
Career Highlights
Throughout his career, Jean-Marc Jeltsch has worked with prominent organizations, including the Institut National de la Santé et de la Recherche Médicale and La Ville Propre. His experience in these institutions has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Jean-Marc has collaborated with notable colleagues such as Christian Bronner and Raphaël Hopfner. These partnerships have further enriched his research and development efforts in the field of cancer diagnostics and treatment.
Conclusion
Jean-Marc Jeltsch's innovative work in the realm of cancer research exemplifies his commitment to improving medical diagnostics and treatment options. His contributions through patents and collaborations highlight the importance of scientific innovation in addressing critical health challenges.